-- Scott is joined by Motley Fool analyst Kate Lee to talk about healthcare software provider Alcidion (ASX:ALC): What it does, what’s impressive, the risks of an investment in the company, and why she thinks it’s a Buy!
See omnystudio.com/listener for privacy information.
